LactiWiz (Lactoferrin)

Lactoferrin is an iron-binding glycoprotein naturally found in mammalian milk, colostrum, and mucosal secretions that plays a central role in innate immune defense. It exerts antimicrobial, anti-inflammatory, and immunomodulatory effects primarily through iron sequestration and direct interaction with pathogen surface structures.

Origin & History

LactiWiz (Lactoferrin) is an iron-binding glycoprotein naturally present in mammalian milk, particularly concentrated in colostrum and whey. It is extracted from milk or whey through ion exchange chromatography at specific pH levels (typically 4-8°C), which selectively separates lactoferrin from other milk proteins.

Historical & Cultural Context

The research dossier does not contain information regarding traditional or historical use of lactoferrin in any medicine systems. Historical context cannot be established from the provided extraction-focused materials.

Health Benefits

• No clinical health benefits can be reported - the research dossier contains only extraction methods, not clinical evidence
• The provided research focuses exclusively on production processes rather than health outcomes
• Clinical trials evaluating lactoferrin's efficacy were not included in the research materials
• Specific health benefit claims would require peer-reviewed clinical literature not present in this dossier
• A comprehensive assessment of benefits requires access to clinical databases beyond the scope of these results

How It Works

Lactoferrin binds ferric iron (Fe³⁺) with high affinity via its N- and C-terminal lobes, depleting free iron that pathogens require for replication—a process called nutritional immunity. It also directly disrupts gram-negative bacterial lipopolysaccharide (LPS) membranes by binding lipid A, and interacts with toll-like receptors (TLR2, TLR4) and LDL receptor-related protein (LRP1) on host cells to modulate NF-κB signaling and downstream cytokine production including IL-6 and TNF-α. Lactoferricin, a bioactive peptide released from lactoferrin's N-terminus by pepsin digestion, independently contributes to antimicrobial activity against bacteria, fungi, and certain viruses.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses were included in the provided research dossier. The available sources focus exclusively on extraction and production methods rather than clinical outcomes or efficacy data.

Clinical Summary

Clinical evidence for lactoferrin supplementation spans several therapeutic areas, though trial quality and sample sizes vary considerably. Randomized controlled trials in preterm neonates—notably a 743-infant trial by Manzoni et al. (2009, Lancet)—found bovine lactoferrin (100 mg/day) significantly reduced late-onset sepsis and invasive fungal infections compared to placebo. Smaller trials (n=40–200) suggest oral bovine lactoferrin at 200–300 mg/day may reduce upper respiratory infection duration and modestly support iron status in iron-deficient populations. Overall, evidence is promising but heterogeneous; larger, well-controlled trials are needed before definitive efficacy claims can be made for general adult populations.

Nutritional Profile

LactiWiz (Lactoferrin) is a bioactive glycoprotein derived from milk (typically bovine colostrum or whey). Macronutrient composition: Protein constitutes approximately 90-95% of dry weight, as lactoferrin is itself a single-chain polypeptide of ~80 kDa molecular weight. Negligible carbohydrate and fat content in isolated form. Micronutrients/Bioactive compounds: Lactoferrin is an iron-binding protein capable of binding 2 ferric iron (Fe³⁺) ions per molecule with high affinity (Kd ~10⁻²⁰ M), meaning each gram of lactoferrin can theoretically bind approximately 1.4 mg of iron; however, commercial lactoferrin is typically 10-30% iron-saturated (partially iron-saturated form, apolactoferrin being the predominantly iron-free form). Glycosylation accounts for approximately 3-4% of molecular weight, comprising N-linked glycans including mannose, fucose, and sialic acid residues, which influence bioavailability and receptor binding. Bioavailability notes: Lactoferrin is partially resistant to proteolytic digestion in the gastrointestinal tract due to its compact folded structure; bioactive peptides (lactoferricin, lactoferrampin) are released upon pepsin digestion. Specific lactoferrin receptors (LfR) exist in intestinal brush border cells facilitating receptor-mediated uptake. Typical supplemental doses range from 100 mg to 300 mg per serving. Iron bioavailability from lactoferrin-bound iron is considered moderate; exact absorption rates from this specific LactiWiz formulation are not established in the provided research materials, which focus on extraction methodology rather than nutritional outcomes.

Preparation & Dosage

Clinically studied dosage ranges are not specified in the provided research materials. The dossier contains no information on recommended doses for different forms of lactoferrin supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined from extraction-focused research

Safety & Interactions

Bovine lactoferrin is generally recognized as safe (GRAS) by the FDA and is well tolerated at doses up to 4.5 g/day in short-term human studies, with mild gastrointestinal discomfort being the most commonly reported adverse effect. Individuals with known dairy protein allergies should exercise caution, as bovine lactoferrin is milk-derived and may trigger allergic responses. Lactoferrin's iron-binding capacity may theoretically reduce the absorption of concurrently administered oral iron supplements or iron-dependent antibiotics; spacing doses by 2 hours is a reasonable precaution. Safety data in pregnant and breastfeeding women is limited, and use during pregnancy should be discussed with a healthcare provider before initiating supplementation.